Overview - The Pregnancy Predicament
- High-stakes balancing act: Untreated maternal bipolar disorder carries significant risks (↑ relapse, psychosis, suicide, poor obstetric outcomes) versus potential teratogenic risks of mood stabilizers.
- Screening is key: Use tools like the Mood Disorder Questionnaire (MDQ) to identify at-risk patients. Must differentiate from normal pregnancy-related mood lability.
⭐ Postpartum Risk: The immediate postpartum period is the time of highest risk for a severe bipolar relapse, including postpartum psychosis, often within the first 4 weeks.

Management - To Treat or Not to Treat
- Risk/Benefit Analysis: A patient-centered decision is paramount. Untreated maternal illness poses significant risks to both mother and fetus (e.g., poor self-care, substance use, suicidality).
- Pre-conception counseling is ideal to plan for medication changes.
⭐ Postpartum Relapse: The risk of relapse is extremely high (>50%) if mood stabilizers are discontinued during pregnancy. Close postpartum follow-up is critical.
Pharmacotherapy - Perilous Pills
Managing bipolar disorder during pregnancy requires balancing maternal mental health and fetal safety. Most mood stabilizers carry significant teratogenic risks.

| Mood Stabilizer | Key Teratogenic Risk(s) | Management Pearls |
|---|---|---|
| Lithium | Ebstein's Anomaly (tricuspid valve) | Risk ~1/1000; requires fetal echocardiogram at 18-20 weeks. Dose may need adjustment. |
| Valproate | Neural Tube Defects (highest risk), developmental delay | Contraindicated. Folate supplementation does not eliminate the high risk. |
| Carbamazepine | Neural Tube Defects | Structurally similar to tricyclic antidepressants; risk profile is a major concern. |
| Lamotrigine | Oral Clefts (small risk) | Generally safer. Plasma levels ↓ during pregnancy, often requiring dose ↑. |
| Atypicals | Metabolic syndrome, neonatal adaptation syndrome | Often a first-line alternative. Less data on long-term neurodevelopment. |
Postpartum & Breastfeeding - The Aftermath
- High Relapse Risk: ↑↑ risk of mood episodes in the postpartum period, especially the first month. Prophylactic treatment is often resumed immediately after delivery.
- Medication & Breastfeeding:
- Avoid Lithium: High milk concentration poses toxicity risk to the infant (hypotonia, lethargy).
- Safer Choices: Lamotrigine and most second-generation antipsychotics are generally preferred.
- Infant Monitoring: Crucial to watch for sedation, poor feeding, and irritability.
⭐ The risk of severe postpartum relapse in women with bipolar disorder can be as high as 50% without prophylactic treatment.
High‑Yield Points - ⚡ Biggest Takeaways
- Lithium is the most effective mood stabilizer but carries a risk of Ebstein's anomaly if used in the first trimester.
- Valproate and carbamazepine are highly teratogenic (neural tube defects) and generally contraindicated.
- Lamotrigine and second-generation antipsychotics (e.g., lurasidone) are often preferred safer alternatives.
- The postpartum period represents the highest-risk time for relapse or psychosis; medication adherence is critical.
- Always counsel patients on risks vs. benefits of untreated illness.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app